BNP Paribas Financial Markets’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-22,156
Closed -$88.6K 4550
2019
Q4
$88.6K Buy
22,156
+11,751
+113% +$55.2K ﹤0.01% 3345
2019
Q3
$51K Sell
10,405
-745
-7% -$4.17K ﹤0.01% 3466
2019
Q2
$67.9K Sell
11,150
-1,954
-15% -$10.4K ﹤0.01% 3246
2019
Q1
$76.1K Buy
13,104
+10,708
+447% +$111K ﹤0.01% 3277
2018
Q4
$32.3K Sell
2,396
-848
-26% -$14.3K ﹤0.01% 2927
2018
Q3
$63K Sell
3,244
-4,037
-55% -$86K ﹤0.01% 2955
2018
Q2
$186K Sell
7,281
-23,422
-76% -$546K ﹤0.01% 2481
2018
Q1
$619K Buy
30,703
+6,332
+26% +$148K ﹤0.01% 2058
2017
Q4
$489K Sell
24,371
-510
-2% -$10K ﹤0.01% 2490
2017
Q3
$515K Buy
24,881
+10,889
+78% +$184K ﹤0.01% 1969
2017
Q2
$207K Buy
13,992
+5,116
+58% +$85.3K ﹤0.01% 2432
2017
Q1
$142K Buy
8,876
+1,073
+14% +$15.5K ﹤0.01% 2366
2016
Q4
$98.3K Buy
7,803
+1,005
+15% +$18.7K ﹤0.01% 2531
2016
Q3
$190K Sell
6,798
-4,904
-42% -$165K ﹤0.01% 1776
2016
Q2
$410K Buy
11,702
+6,583
+129% +$207K ﹤0.01% 1595
2016
Q1
$140K Sell
5,119
-1,827
-26% -$53.8K ﹤0.01% 1672
2015
Q4
$238K Sell
6,946
-525
-7% -$16.4K ﹤0.01% 1821
2015
Q3
$215K Buy
7,471
+4,461
+148% +$191K ﹤0.01% 1904
2015
Q2
$135K Buy
3,010
+2,643
+720% +$99.4K ﹤0.01% 1919
2015
Q1
$12.7K Buy
+367
New +$9.99K ﹤0.01% 2615

Other funds holding DPLO

BNP Paribas Financial Markets's DPLO Position: Q1 2020 in Review

BNP Paribas Financial Markets sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2020, closing a stake of 22,156 shares — an estimated $88.6K sold.

BNP Paribas Financial Markets first reported a position in DPLO in Q1 2015 and held it in 20 quarters. The position peaked at $619K in Q1 2018. 1 fund tracked by Wall St. Rank holds DPLO as of Q1 2020.

  • BNP Paribas Financial Markets reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2020 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 22,156 DIPLOMAT PHARMACY, INC. shares in Q1 2020, an estimated $88.6K.
  • BNP Paribas Financial Markets first reported a position in DIPLOMAT PHARMACY, INC. in Q1 2015 and held it in 20 quarters.
  • BNP Paribas Financial Markets's DIPLOMAT PHARMACY, INC. position peaked at $619K in Q1 2018.
  • 1 fund tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2020.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2020, filed 13 May 2020.